Interferon-gamma
Contents
Description
Interferon gamma-1b is a biologic immunomodulator used to reduce the frequency and severity of serious infections in patients with chronic granulomatous disease and severe malignant osteopetrosis. It enhances phagocyte function and has been studied in various primary immunodeficiencies with susceptibility to mycobacterial and viral infections. The drug activates macrophages and enhances antimicrobial activity.
Indications & Therapeutic Use
Chronic granulomatous disease, severe malignant osteopetrosis, susceptibility to mycobacterial infections
Linked Diseases:
Global Availability (6 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Interferon-gamma — GNH India
7 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Interferon-gamma products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | Interferon-gamma |
| Brands | 1 brand available |
| Active Ingredient | Interferon gamma-1b |
| Drug Class | Chronic granulomatous disease |
| Manufacturer | Horizon Therapeutics |
| Dosage Forms | Subcutaneous injection 100 mcg (2 million IU)/0.5 mL |
| Medical Code | L03AB03 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 14 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00006463 |
| Countries | 6 countries |